Wells Fargo & Company Kamada LTD Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Kamada LTD stock. As of the latest transaction made, Wells Fargo & Company holds 606,300 shares of KMDA stock, worth $4.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

606,300

Previous 610,466 0.68%

Holding current value

$4.26 Million

Previous $4.73 Million 11.33%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$6.67 - $8.02 $27,787 - $33,411	-4,166 Reduced 0.68%	606,300 $4.2 Million
Q2 2025 Aug 14, 2025	BUY	$5.76 - $8.12 $10,805 - $15,233	1,876 Added 0.31%	610,466 $4.73 Million
Q1 2025 May 13, 2025	SELL	$6.33 - $8.33 $139,880 - $184,076	-22,098 Reduced 3.5%	608,590 $4.02 Million
Q4 2024 Feb 12, 2025	BUY	$5.17 - $6.27 $4,156 - $5,041	804 Added 0.13%	630,688 $3.84 Million
Q3 2024 Nov 13, 2024	SELL	$4.83 - $6.25 $38,041 - $49,225	-7,876 Reduced 1.23%	629,884 $3.38 Million

Q2 2024 Aug 13, 2024	BUY	$4.78 - $5.75 $62,106 - $74,709	12,993 Added 2.08%	637,760 $3.16 Million
Q1 2024 May 10, 2024	SELL	$5.58 - $6.42 $132,519 - $152,468	-23,749 Reduced 3.66%	624,767 $3.5 Million
Q4 2023 Feb 09, 2024	SELL	$4.14 - $6.22 $4,554 - $6,842	-1,100 Reduced 0.17%	648,516 $3.97 Million
Q3 2023 Nov 13, 2023	BUY	$4.86 - $5.83 $20,402 - $24,474	4,198 Added 0.65%	649,616 $3.47 Million
Q2 2023 Aug 15, 2023	BUY	$4.48 - $5.53 $33,008 - $40,745	7,368 Added 1.15%	645,418 $3.41 Million
Q1 2023 May 12, 2023	BUY	$4.12 - $5.25 $511,596 - $651,913	124,174 Added 24.16%	638,050 $2.96 Million
Q4 2022 Feb 13, 2023	BUY	$3.79 - $4.84 $83,429 - $106,542	22,013 Added 4.48%	513,876 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$4.42 - $5.43 $221,760 - $272,433	50,172 Added 11.36%	491,863 $2.18 Million
Q2 2022 Aug 12, 2022	BUY	$4.22 - $5.85 $21,197 - $29,384	5,023 Added 1.15%	441,691 $2.03 Million
Q1 2022 May 16, 2022	SELL	$5.43 - $6.81 $94,856 - $118,963	-17,469 Reduced 3.85%	436,668 $2.41 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $6.82 $35,579 - $46,573	6,829 Added 1.53%	454,137 $2.99 Million
Q3 2021 Nov 15, 2021	BUY	$5.25 - $5.87 $977,576 - $1.09 Million	186,205 Added 71.31%	447,308 $2.37 Million
Q2 2021 Aug 16, 2021	BUY	$5.67 - $6.33 $56 - $63	10 Added 0.0%	261,103 $1.52 Million
Q1 2021 May 13, 2021	BUY	$6.02 - $8.06 $723,929 - $969,247	120,254 Added 85.38%	261,093 $1.62 Million
Q4 2020 Feb 09, 2021	BUY	$6.3 - $8.46 $886,668 - $1.19 Million	140,741 Added 143613.27%	140,839 $913,000
Q3 2020 Nov 05, 2020	SELL	$8.02 - $11.73 $3,224 - $4,715	-402 Reduced 80.4%	98 $1,000
Q2 2020 Aug 13, 2020	BUY	$5.37 - $9.45 $2,685 - $4,725	500 New	500 $4,000

Others Institutions Holding KMDA

# of Institutions

Shares Held

5.96M

Call Options Held

Put Options Held

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $315M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Kamada LTD Transaction History